How to access Doptelet from India, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Indian patient with chronic immune thrombocytopenia (ITP) who has had insufficient response to previous therapy, or an Indian patient with thrombocytopenia secondary to chronic liver disease who is scheduled for an elective procedure, may receive a prescription for Doptelet (avatrombopag) from their treating haematologist or hepatologist. Doptelet is FDA-approved for chronic ITP in adults with insufficient response to previous therapy, and for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure. It is manufactured by Sobi. Doptelet is a small-molecule thrombopoietin (TPO) receptor agonist taken orally, and it does not require the meal-timing-independent and food-interaction complexities that characterise some other oral TPO-RAs. In India, Doptelet may not yet be broadly registered, which is why your physician may be navigating a named-patient import pathway with you.
This guide explains the legal pathway, what documentation your physician needs, typical costs and timing, and where Reserve Meds fits in.
Note on context: This guide replaces a prior planned entry for Adakveo (crizanlizumab) × India. Doptelet is substituted as a commercially stable hematology pair at comparable rank.
Ask about Doptelet in India
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Doptelet is an oral tablet. For chronic ITP, dosing is initiated at 20 mg once daily with food and titrated based on platelet response (target platelet count typically ≥50 × 10⁹/L). For chronic liver disease thrombocytopenia prior to a procedure, dosing is weight-independent at 40-60 mg daily for 5 days starting 10-13 days before the procedure. Doptelet should be taken with food for optimal absorption. Your treating physician confirms diagnosis, baseline labs (platelets, liver function, prior-therapy history for ITP), and the dosing plan per FDA labeling.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Doptelet legally importable into India?
Yes, through the Central Drugs Standard Control Organization (CDSCO) named-patient / personal-use import framework. The pathway allows an Indian-licensed physician (or the patient directly, with physician prescription) to request import of a medicine not locally registered when: (a) the medicine is approved by a recognised reference authority (FDA qualifies), (b) no clinically equivalent registered alternative fits, (c) the physician takes clinical responsibility, and (d) the imported quantity is proportionate to a defined treatment period.
For avatrombopag specifically, the application is routine, an oral tablet with standard room-temperature handling and no REMS or controlled-substance complexity.
How the pathway works, step by step
- Consultation with your treating physician. ITP or chronic-liver-disease-associated thrombocytopenia diagnosis, prior therapy history (for ITP), baseline labs, and clinical rationale for Doptelet.
- CDSCO named-patient / personal-use application. Your physician or the importing pharmacy files the application.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner.
- Shipment. Doptelet ships at controlled room temperature; no cold-chain is required.
- Arrival and dosing start. The treating physician initiates titrated dosing (for ITP) or the 5-day procedural course (for chronic liver disease thrombocytopenia).
What documentation your physician needs
Your physician will typically need to provide:
- Clinical rationale letter confirming chronic ITP with insufficient response to prior therapy, or chronic liver disease thrombocytopenia prior to procedure, baseline labs, and Doptelet as indicated treatment
- Verification of Indian medical licence
- Patient identifier
- Planned dosing schedule and projected tablet count
Reserve Meds provides a physician documentation kit that bundles the templates CDSCO reviewers expect to see.
Costs and timing
Medicine price: quote on request. You get a written quote for your case before you commit. International logistics, CDSCO documentation, and coordination add incremental cost; Reserve Meds issues a full transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. For procedural dosing in chronic liver disease, the 10-13-day pre-procedure window must be factored into application timing.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Doptelet specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and for CDSCO review.
- Logistics. Controlled-room-temperature shipment.
- Dedicated case lead. A named point of contact.
What we do not do: We are not the prescriber. We do not practise medicine. We are not the dispensing pharmacy. All clinical decisions remain with your treating physician.
Frequently asked
Is this legal in India? Yes, when executed through the CDSCO named-patient / personal-use framework with appropriate documentation.
How does Doptelet compare with eltrombopag or romiplostim? All three are TPO-receptor agonists. Eltrombopag (Promacta/Revolade) is oral but has strict dietary-cation restrictions and requires fasting. Romiplostim (Nplate) is a weekly subcutaneous injection. Doptelet is oral, taken with food, without the cation-restriction complexity of eltrombopag, a practical advantage for many patients. Your physician chooses based on clinical profile and practical factors.
Why am I seeing this guide labelled as a substitute for Adakveo? Adakveo (crizanlizumab) was the originally planned pair for this slot. Its commercial status has shifted in multiple international markets following post-marketing data. Doptelet replaces Adakveo as a commercially stable hematology pair at comparable rank.
Will private insurance cover this? Cash-pay is the default. Some Indian private insurers reimburse named-patient ITP therapy on escalated review; we supply documentation but do not process insurance claims directly.
Next step
For Doptelet coordination in India, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
Examples and timings above are composite illustrations drawn from published sources and typical named-patient patterns. Your individual case is assessed by your physician and our clinical-regulatory team; Reserve Meds does not guarantee outcomes or timelines.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Frequently asked questions
How can I get Doptelet in India if it is not approved or available there?
Reserve Meds coordinates US-sourced Doptelet for patients in India through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for India and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Doptelet in India through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Doptelet. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in India, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Doptelet in India through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Doptelet to a patient in India?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Doptelet to your treating physician or hospital pharmacy in India, with appropriate handling for the product.
How long does it take, and what does Doptelet in India cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Doptelet in India?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.